Sofinnova Investments’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-547,707
| Closed | -$20.3M | – | 65 |
|
|
2024
Q2 | $20.3M | Sell |
547,707
-254,070
| -32% | -$9.4M | 1.05% | 25 |
|
|
2024
Q1 | $33.7M | Sell |
801,777
-42,231
| -5% | -$1.77M | 1.87% | 19 |
|
|
2023
Q4 | $33.5M | Buy |
844,008
+419,749
| +99% | +$16.6M | 1.87% | 14 |
|
|
2023
Q3 | $11.7M | Buy |
424,259
+226,501
| +115% | +$6.23M | 0.74% | 31 |
|
|
2023
Q2 | $6.71M | Sell |
197,758
-221,639
| -53% | -$7.52M | 0.44% | 35 |
|
|
2023
Q1 | $15.1M | Buy |
+419,397
| New | +$15.1M | 0.97% | 27 |
|
|
2022
Q3 | – | Sell |
-48,304
| Closed | -$1.3M | – | 54 |
|
|
2022
Q2 | $1.3M | Buy |
+48,304
| New | +$1.3M | 0.11% | 49 |
|
|
2022
Q1 | – | Sell |
-271,533
| Closed | -$10.5M | – | 62 |
|
|
2021
Q4 | $10.5M | Buy |
271,533
+134,501
| +98% | +$5.2M | 0.61% | 39 |
|
|
2021
Q3 | $7.4M | Buy |
137,032
+2,308
| +2% | +$125K | 0.44% | 41 |
|
|
2021
Q2 | $4.51M | Buy |
+134,724
| New | +$4.51M | 0.26% | 49 |
|